Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores.
Na-Ling KangQing-Fa RuanDe-Sheng ZhangXue-Ping YuZhen-Ting HuZhi-Min LinLu-Ying WuMeng-Xin LinZu-Xiong HuangJia-Ji JiangYu-Rui LiuRi-Cheng MaoDa-Wu ZengPublished in: Journal of clinical and translational hepatology (2022)
The GPSA model allows for accurate diagnosis of liver fibrosis in chronic HBV carriers with different ULN for ALT.